Rational molecular design converting fascaplysin derivatives to potent broad-spectrum inhibitors against bacterial pathogens via targeting FtsZ
Authors:
- 23 March 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 270, 116347
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Ningbo Science and Technology Bureau
This publication has 71 references indexed in Scilit:
- Derivatization of Marine‐Derived Fascaplysin via Highly Regioselective Suzuki‐Miyaura Coupling Contributing to the Enhanced Antibacterial ActivityChemistrySelect, 2022
- The Science of Antibiotic DiscoveryCell, 2020
- A Gestalt approach to Gram-negative entryBioorganic & Medicinal Chemistry, 2016
- 3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agentsBioorganic & Medicinal Chemistry, 2012
- 3-Bromohomofascaplysin A, a fascaplysin analogue from a Fijian Didemnum sp. ascidianBioorganic & Medicinal Chemistry, 2011
- The anticancer activity of 3- and 10-bromofascaplysins is mediated by caspase-8, -9, -3-dependent apoptosisBioorganic & Medicinal Chemistry, 2010
- Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZBioorganic & Medicinal Chemistry Letters, 2009
- Very fast empirical prediction and rationalization of protein pKa valuesProteins: Structure, Function, and Bioinformatics, 2005
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulationsJournal of Computational Chemistry, 2001